Phase 1 study of CTX-471, a novel CD137 agonist antibody, in patients with progressive disease following PD-1/PD-L1 inhibitors in metastatic or locally advanced malignancies.

Wednesday, June 19, 2024

Dr. Minal Barve

Click above link to view abstract, login required to view video presentation.

ASCO 2024 Poster for Trial 19-09

ASCO 2024 Poster for Trial 19-09